Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-25 @ 1:39 AM
NCT ID:
NCT01973894
Eligibility Criteria:
Inclusion Criteria:
* ICU admittance
* Caucasian
* Clinical indication of least 72h of continuous sedation with Midazolam
* MAP between 60 - 150 mmHg, even if obtained with amine support
* informed consent obtained
Exclusion Criteria:
* Any endocranial lesion, spontaneous or induced
* PaCO2 \> 60 mmHg or \< 30 mmHg
* PaO2 \< 50 mmHg
* Pregnancy
* Anuria
* Any transplantation
* Severe hepatic failure (Child C)
* Life expectancy \< 72h
* Ketoconazole and antiretrovirals in therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01973894
Study Brief:
Protocol Section:
NCT01973894